Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bifeprunox in Bipolar Depression
NCT00245973Phase 3Completed
- Sponsor
- Pfizer
- Start
- Jun 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of bifeprunox in bipolar disorder (BD), sponsored by Pfizer. Started Jun 2005; status: completed.
02
Drugs
bifeprunox
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on NCT00245973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00245973.